Nutex Health Inc. (NUTX) Stock Price & Analysis
Nutex Health Inc. (NUTX) fell 2.25% to USD 193.24 as of September 8, 2026 at 06:22 UTC, according to Nexqual real-time market data.
NUTX last closed at USD 193.24; the session ranged USD 190.66–200 on volume of 142,279 shares. Market capitalization is —, with a 52-week range of USD 80.53–204 (NCM). Source: Nexqual, September 8, 2026 at 06:22 UTC.
Key Statistics (as of September 8, 2026 at 06:22 UTC)
| Price | USD 193.24 |
|---|---|
| Change | ▼ 2.25% (down) |
| Previous Close | USD 193.24 |
| Open | USD 193.24 |
| Day Range | USD 190.66 – 200 |
| 52-Week Range | USD 80.53 – 204 |
| Volume | 142,279 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (NUTX)
Nexqual's technical model rates NUTX "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:22 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.45 (neutral) |
| vs SMA50 | Above (USD 174.99) |
| MACD | 7.09 (positive) |
From Nutex Health Inc.'s Latest SEC 10-K Filing (filed 2026-03-05)
Key Strengths & Strategy (as disclosed to the SEC)
- Based on the information and data we provide to HaloMD, using a proprietary data driven process, HaloMD submits the required documentation to the CIDRE through the federal portal. • Eligibility Determination.
- HaloMD, using proprietary data analysis and benchmarking, determines the appropriate offer amount on our behalf. • Independent Review .
- We believe our business, partnership and operations model enables us to compete favorably.
- Human Capital Management Attracting, developing, and retaining talented people who embrace our culture, execute our strategy, and enable us to compete effectively in our industry is critical to our success.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ILAG | Intelligent Living Application | USD 2.9 | ▲ 0% |
| REVB | Revelation Biosciences, Inc. | USD 1.01 | ▲ 1% |
| QNRX | Quoin Pharmaceuticals, Ltd. | USD 7.26 | ▲ 7.72% |
| KPRX | Kiora Pharmaceuticals, Inc. | USD 2.55 | ▼ 1.54% |
| MEGL | Magic Empire Global Limited | USD 1.24 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:22 UTC. This page is informational and not investment advice.